Brand Name: WINREVAIR Generic Name: (sotatercept-csrk). WINREVAIR (sotatercept-csrk) is used to treat pulmonary arterial hypertension.
WINREVAIR is an activin signaling inhibitor indicated for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of clinical worsening events.
Brand Name: | WINREVAIR |
Generic Name: | sotatercept-csrk |
Strength: | • For injection: 45 mg lyophilized cake or powder in a single-dose vial • For injection: 60 mg lyophilized cake or powder in a single-dose vial |
Manufacturer: | Merck Sharp & Dohme LLC |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “WINREVAIR (sotatercept-csrk)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for WINREVAIR (sotatercept-csrk) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.